Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Zecotek Files Suit Against Saint-Gobain, Philips

Photonics.com
Feb 2012
SINGAPORE, Feb. 24, 2012 — Zecotek Imaging Systems Pte Ltd., a subsidiary of Zecotek Photonics Inc., has filed a patent suit in the US against Saint-Gobain Corp. and Philips for infringing its US Patent No. 7,132,060, the company announced.

The patent covers the substances and chemical formulations used to grow lutetium fine silicate (LFS) scintillation crystals, which are characterized by their combined high light yield and ultrafast decay times and typically are used in medical scanning devices. The lawsuit alleges that Saint-Gobain’s LYSO crystals infringe Zecotek’s patent, and that Philips infringes by using those crystals in the PET scanners it sells.

“We believe that this patent is fundamental, and that damages are very substantial,” said Dr. A.F. Zerrouk, chairman, president and CEO of Zecotek Photonics Inc. “We are determined to vigorously enforce our intellectual property rights to recover damages afflicted on Zecotek and the lost value to our shareholders.”

The patent that covers Zecotek’s LFS scintillation crystals was granted Nov. 6, 2006.

Zecotek is joined by its exclusive licensee for certain LFS crystals, Beijing Opto-Electronics Technology Co. Ltd., as co-plaintiff.

Zecotek Photonics Inc. develops crystals, photodetectors, medical lasers, optical imaging and 3-D display technologies for commercial applications in the medical diagnostics and high-tech industry.

For more information, visit: www.zecotek.com  


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.